血管平滑肌脂肪瘤患者的肾功能结局:监测与栓塞与肾切除术的比较
这项两中心回顾性研究分析了318例血管平滑肌脂肪瘤(AML)患者,平均随访6.2年。监测组184例(57.9%)、栓塞组30例(9.4%)、手术组103例(32.4%)。与监测组相比,栓塞和手术组最新肾小球滤过率(GFR)下降更多(P=.02)。作者认为监测对多数AML患者似乎是合适的,栓塞和手术应保留给特定的大且/或有症状的AML患者。
要点
- 监测组AML肿瘤较小(1.9 cm),小于栓塞组(5.4 cm)和手术组(4.9 cm)(P<.001)。
- 最新GFR下降幅度:栓塞组-14.1%和手术组-14.7%,均大于监测组-6.0%(P=.02)。
- 至少一个分期的慢性肾脏病进展总体发生率为37.8%,三组间无统计学差异(P=.074)。
核心结论
- 在研究局限性范围内,监测似乎对多数AML患者是合适的;栓塞和手术干预应保留给特定的大和/或有症状的AML患者。
- 无论采用监测、栓塞还是手术,AML患者的肾功能恶化均常见。
- 所有AML患者均应长期监测肾功能。
研究设计与样本
- 两中心回顾性纵向数据分析,纳入318例诊断为AML的患者,平均随访6.2年。
- 按治疗类型分组:监测组184例(57.9%)、栓塞组30例(9.4%)、手术组103例(32.4%),其中手术组包括91例部分肾切除术和12例根治性肾切除术。
主要发现
- 监测组AML肿瘤大小1.9 cm,小于栓塞组5.4 cm和手术组4.9 cm(P<.001)。
- 诊断至诊断后6个月内的中期GFR下降:栓塞组-14.0%、手术组-11.8%、监测组-4.1%,但无统计学显著性(P=.19)。
- 最新GFR下降:栓塞组-14.1%和手术组-14.7%,均大于监测组-6.0%(P=.02)。
- 最新评估时至少一个分期的慢性肾脏病进展总体发生率为37.8%,其中监测组为33.7%,三组间无统计学差异(P=.074)。
- 基线特征包括肿瘤大小、年龄和种族在三组间存在差异(P<.05)。
临床怎么用
- 作者认为监测似乎对多数AML患者是合适的。
- 作者认为栓塞和手术干预应保留给特定的大和/或有症状的AML患者。
- 作者认为所有AML患者均应长期监测肾功能。
局限性
- 原文提及研究存在局限性,但未具体说明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate renal functional outcomes of surveillance, embolization, and surgery for angiomyolipomas (AML). METHODS: Longitudinal data regarding patients with AML were analyzed retrospectively in this 2-center study. Demographic, radiographic, and functional data were tabulated according to treatment type. Primary outcome was change in renal function from diagnosis to within 6 months postdiagnosis (interim) and to latest glomerular filtration rate (GFR) assessment. RESULTS: 318 patients were diagnosed with AMLs; mean follow-up was 6.2 years. 184 patients (57.9%) were managed with surveillance, 30 (9.4%) underwent embolization, and 103 (32.4%) underwent surgery (91 partial nephrectomy; 12 radical nephrectomy). Baseline characteristics, including tumor size, age, and race differed between the 3 groups (P<.05). Surveilled AMLs were smaller (P<.001) than the intervention groups: 1.9 cm vs 5.4 cm (embolization) and 4.9 cm (surgery). Greater interim decreases in GFR were observed following intervention with embolization (-14.0%) or surgery (-11.8%), when compared with surveillance (-4.1%); however, this was not statistically significant (P=.19). Latest GFR was also reduced more (P=.02) with embolization (-14.1%) and surgery (-14.7%) when compared to surveillance (-6.0%). At latest determination, chronic kidney disease progression by at least one stage occurred in 37.8% overall, including 33.7% of surveilled patients, and was not statistically different across the three cohorts (P=.074). CONCLUSION: Within the study limitations, surveillance appears to be appropriate for most AML patients; embolization and surgical intervention should be reserved for selected patients with large and/or symptomatic AML. Renal functional deterioration is common in patients with AML, whether managed with surveillance, embolization, or surgery. Long-term monitoring of renal function should be obligatory for all AML patients.
引用
- Mora S, Derweesh I, Meagher M, et al. Renal Functional Outcomes in Patients With Angiomyolipomas: Surveillance vs Embolization vs Nephrectomy. Urology. 2022. PMID: 36572219. doi:10.1016/j.urology.2022.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。